The Composition of Bone

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Volumn , Issue , 2013, Pages 49-58

  Boskey, Adele L ^a   Robey, Pamela Gehron ^b  

^a Weill Cornell Medical Center   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Bone composition; Extracellular matrix (ECM); Noncollagenous proteins (NCPs)

Indexed keywords

EID: 85006052600     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118453926.ch6     Document Type: Chapter

References (40)

1. Lian JB, Stein GS. 2006 The cells of bone. In: Seibel MJ, Robins SJ, Bilezikian JP (eds.) Dynamics of Bone and Cartilage Metabolism. San Diego: Academic Press. pp. 221-58.
2. Zhu W, Robey PG, Boskey AL. 2007. The regulatory role of matrix protines in mineralization of bone. In: Marcus R, Feldman D, Nelson DA, Rosen CJ (eds.) Osteoporosis, Vol. 1. San Diego: Academic Press. pp. 191-240.
3. Shekaran A, Garcia AJ. 2011. Extracellular matrixmimetic adhesive biomaterials for bone repair. J Biomed Mater Res A 96 (1): 261-72.
4. Grynpas MD, Omelon S. 2007. Transient precursor strategy or very small biological apatite crystals? Bone 41 (2): 162-4.
5. Dorozhkin SV. 2010. Amorphous calcium (ortho)phosphates. Acta Biomater 6 (12): 4457-75.
6. Boskey AL. 2006. Organic and inorganic matrices. In: Wnek G, Bowlin GL (eds.) Encyclopedia of Biomaterials and Biomecial Engineering. London, UK: Dekker Encyclopedias, Taylor & Francis Books. pp. 1-15.
7. Boskey AL. 2007. Osteoporosis and osteopetrosis. In: Baeuerlein E, Bchrens P, Epple M (eds.) Biomineralization in Medicine, Vol. 7. New York: Wiley. pp. 59-75.
8. Rossert J, de Crombrugghe B. 2002. Type I collagen: Structure, synthesis and regulation. In: Bilezikian JP, Raisz LA, Rodan GA (eds.) Principles of Bone Biology, 2nd Ed., Vol 1. San Diego: Academic Press. pp. 189-210.
9. Pagani F, Francucci CM, Moro L. 2005. Markers of bone turnover: Biochemical and clinical perspectives. J Endocrinol Invest 28 (10 Suppl): 8-13.
10. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. 2003. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112 (3): 357-66.
11. Robey PG. 2008. Non-collagenous bone matrix proteins. In: Bilezikian JP, Raisz LA, Rodan GA (eds.) Principles of Bone Biology, Vol. 1. San Diego: Academic Press. pp. 335-50.
12. Igwe JC, Gao Q, Kizivat T, Kao WW, Kalajzic I. 2011. Keratocan is expressed by osteoblasts and can modulate osteogenic differentiation. Connect Tissue Res 52 (5): 401-7.
13. Schaefer L, Iozzo RV. 2008. Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction. J Biol Chem 283 (31): 21305-9.
14. Nuka S, Zhou W, Henry SP, Gendron CM, Schultz JB, Shinomura T, Johnson J, Wang Y, Keene DR, Ramirez-Solis R, Behringer RR, Young MF, Hook M. 2010. Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. Osteoarthritis Cartilage 18 (1): 88-96.
15. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millan JL. 2004. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164 (3): 841-7.
16. Delany AM, Hankenson KD. 2009. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal 3 (3-4): 227-38.
17. Kimura H, Akiyama H, Nakamura T, de Crombrugghe B. 2007. Tenascin-W inhibits proliferation and differentiation of preosteoblasts during endochondral bone formation. Biochem Biophys Res Commun 356 (4): 935-41.
18. Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A. 2010. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 285 (3): 2028-39.
19. Paz J, Wade K, Kiyoshima T, Sodek J, Tang J, Tu Q, Yamauchi M, Chen J. 2005. Tissue-and bone cellspecific expression of bone sialoprotein is directed by a 9.0 kb promoter in transgenic mice. Matrix Biol 24 (5): 341-52.
20. Wade-Gueye NM, Boudiffa M, Laroche N, Vanden-Bossche A, Fournier C, Aubin JE, Vico L, Lafage-Proust MH, Malaval L. 2010. Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment. Endocrinology 151 (11): 5103-13.
21. Huffman NT, Keightley JA, Chaoying C, Midura RJ, Lovitch D, Veno PA, Dallas SL, Gorski JP. 2007. Association of specific proteolytic processing of bone sialoprotein and bone acidic glycoprotein-75 with mineralization within biomineralization foci. J Biol Chem 282 (36): 26002-13.
22. Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. 2007. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 41 (3): 462-73.
23. Qin C, Baba O, Butler WT. 2004. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15 (3): 126-36.
24. Prasad M, Butler WT, Qin C. 2010. Dentin sialophosphoprein in biomineralization. Connect Tissue Res 51: 404-17.
25. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. 2008. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 283 (26): 17991-8001.
26. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (6620): 78-81.
27. Murshed M, Schinke T, McKee MD, Karsenty G. 2004. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 165 (5): 625-30.
28. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382 (6590): 448-52.
29. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. 1998. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23 (3): 187-96.
30. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130 (3): 456-69.
31. Kumar R, Vella A. 2011. Carbohydrate metabolism and the skeleton: Picking a bone with the beta-cell. J Clin Endocrinol Metab 96 (5): 1269-71.
32. Bonnet N, Standley KN, Bianchi EN, Stadelmann V, Foti M, Conway SJ, Ferrari SL. 2009. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem 284 (51): 35939-50.
33. Trackman PC. 2005. Diverse biological functions of extracellular collagen processing enzymes. J Cell Biochem 96 (5): 927-37.
34. Ge G, Greenspan DS. 2006. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 78 (1): 47-68.
35. Yadav MC, Simao AM, Narisawa S, Huesa C, McKee MD, Farquharson C, Millan JL. 2011. Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: A unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res 26 (2): 286-97.
36. Goldberg M, Boskey AL. 1996. Lipids and biomineralizations. Prog Histochem Cytochem 31 (2): 1-187.
37. Stoffel W, Jenke B, Block B, Zumbansen M, Koebke J. 2005. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc Natl Acad Sci U S A 102 (12): 4554-9.
38. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, Auge N, Salvayre R, Negre-Salvayre A, Goldberg M, Guenet JL, Poirier C. 2005. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 37 (8): 803-5.
39. Rubin J, Schwartz Z, Boyan BD, Fan X, Case N, Sen B, Drab M, Smith D, Aleman M, Wong KL, Yao H, Jo H, Gross TS. 2007. Caveolin-1 knockout mice have increased bone size and stiffness. J Bone Miner Res 22 (9): 1408-18.
40. Gregory P, Kraemer E, Zurcher G, Gentinetta R, Rohrbach V, Brodbeck U, Andres AC, Ziemiecki A, Butikofer P. 2005. GPI-specific phospholipase D (GPI-PLD) is expressed during mouse development and is localized to the extracellular matrix of the developing mouse skeleton. Bone 37 (2): 139-47.